Synergistic Drug Combinations in AIDS Therapy
- 17 December 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 616 (1), 367-384
- https://doi.org/10.1111/j.1749-6632.1990.tb17857.x
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Synergistic Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Replication In Vitro by Recombinant Soluble CD4 and 3'-Azido-3'-DeoxythymidineThe Journal of Infectious Diseases, 1989
- New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral ActivityJNCI Journal of the National Cancer Institute, 1989
- Enhancement of 5-fluorouracil's anticancer activity by dipyridamolePharmacology & Therapeutics, 1989
- Nucleoside and nucleobase transport in animal cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1988
- 2′,3′-Dideoxythymidine permeation of the human erythrocyte membrane by nonfacilitated diffusionBiochemical and Biophysical Research Communications, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- DipyridamoleNew England Journal of Medicine, 1987
- Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related DisordersNew England Journal of Medicine, 1987
- Interaction of [3H]dipyridamole with the nucleoside transporters of human erythrocytes and cultured animal cellsThe Journal of Membrane Biology, 1987
- The effect of 3-deazauridine and dipyridamole on uridine utilization by miceEuropean Journal of Cancer and Clinical Oncology, 1986